DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tyloxapol
Tyloxapol
Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme
WO 2016/074683 Al 19 May 2016 (19.05.2016) W P O P C T
Marrakesh Agreement Establishing the World Trade Organization
Alphabetical Listing of ATC Drugs & Codes
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 6,638,537 B2 Dennis Et Al
Supplementary File 2. Symptomatic Drugs Assigned to ALS Treatment
Pharmacy Data Management Drug Exception List
Bureau of Prisons Health Services 2018 Summer National Formulary (Part 2)
Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - a Double-Blind, Randomized Controlled Trial
Electronic Supplementary Material
Combined Index to USP 41 and NF 36, Volumes 1–5
Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme
Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement
Business Impact Analysis
Atc Index 2010
Gpi Drug Classification Report
A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide
Top View
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
„ Wo 2012/012498 A2
Repurposing of Drugs As Novel Influenza Inhibitors from Clinical Gene
A Full Cycle Anti-Viral Drug Screen Identifies a Clinical Compound
Australian Statistics on Medicines 2009
Aerosol Therapy in Pulmonary Critical Care
Excipients in the Paediatric Population: a Review
Title 21 Food and Drugs Parts 300 to 499
Evaluating the Need for an Orphan Drug Act in India by Comparing It with the US Orphan
Drugs Used in the Treatment of the Common Cold
A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
Gold Standard Drug Monographs
U.S. EQUINE Zoetis EQUINE Products ANTI-INFLAMMATORIES
(12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al
To USP 39–NF 34, Second Supplement the Following Index Is
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop
Subchapter D—Drugs for Human Use
(19) United States (12) Patent Application Publication (10) Pub
Download Original
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Abstract This Material Provides Documentation for Users of The
Influence of Surfactants on the Absorption of Drugs
Combined Index to USP 40 and NF 35, Volumes 1–4
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Australian Statistics on Medicines 2003
Non-FDA Approved Medication and Product List